Literature DB >> 8069305

Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene.

F M Richards1, P A Crossey, M E Phipps, K Foster, F Latif, G Evans, J Sampson, M I Lerman, B Zbar, N A Affara.   

Abstract

Von Hippel-Lindau disease is a dominantly inherited familial cancer syndrome characterised by the development of retinal angiomatosis, cerebellar and spinal hemangioblastoma, renal cell carcinoma, phaeochromocytoma and pancreatic tumours. A cDNA (g7) which detects frequent genomic rearrangements in VHL disease patients on Southern analysis, and contains the partial coding sequence of the VHL gene has been isolated recently. To characterise the nature of the genomic rearrangements in VHL disease we initially screened 116 patients with VHL disease and identified 22 patients (19%) with abnormal fragments in EcoR1 digested DNA probes with g7. We then established that the coding sequence contained within g7 is represented in 3 exons, and design exon specific probes to investigate the 22 patients with genomic rearrangements. All 22 patients were demonstrated to have germline deletions, but the deletions were heterogeneous with 7 patients having deletions confined to the 5' exon 1, and 8 with nonoverlapping deletions of exon 3. In 7 unrelated patients, including 2 new mutations, the germline deletions were similar in size and position. There was no relationship between the clinical phenotype and the deletion of individual exons. Although phaeochromocytoma was less frequent in kindreds with germline deletions than those without detectable deletions, the difference was not statistically significant (1/19 versus 16/72 respectively, chi 2 = 1.84 p > 0.1).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8069305     DOI: 10.1093/hmg/3.4.595

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  14 in total

1.  A genetic register for von Hippel-Lindau disease.

Authors:  I R Maddock; A Moran; E R Maher; M D Teare; A Norman; S J Payne; R Whitehouse; C Dodd; M Lavin; N Hartley; M Super; D G Evans
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

2.  LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome.

Authors:  E Volikos; J Robinson; K Aittomäki; J-P Mecklin; H Järvinen; A M Westerman; F W M de Rooji; T Vogel; G Moeslein; V Launonen; I P M Tomlinson; A R J Silver; L A Aaltonen
Journal:  J Med Genet       Date:  2006-05       Impact factor: 6.318

Review 3.  Hereditary kidney cancer syndromes.

Authors:  Naomi B Haas; Katherine L Nathanson
Journal:  Adv Chronic Kidney Dis       Date:  2014-01       Impact factor: 3.620

4.  Von Hippel-Lindau gene product directs cytokinesis: a new tumor suppressor function.

Authors:  Sutapa Sinha; Gourish Mondal; Eun Ju Hwang; Da Woon Han; Shamit K Dutta; Seethalakshmi Iyer; S Ananth Karumanchi; Keun Il Kim; Fergus J Couch; Debabrata Mukhopadhyay
Journal:  J Cell Sci       Date:  2011-06-07       Impact factor: 5.285

5.  Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.

Authors:  Israel Gomy; Greice Andreotti Molfetta; Ester de Andrade Barreto; Cristiane Ayres Ferreira; Dalila Luciola Zanette; José Cláudio Casali-da-Rocha; Wilson Araujo Silva
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

6.  Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.

Authors:  V H Haase; J N Glickman; M Socolovsky; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

7.  Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.

Authors:  H J Decker; C Neuhaus; A Jauch; M Speicher; T Ried; M Bujard; H Brauch; S Störkel; M Stöckle; B Seliger; C Huber
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

8.  Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes.

Authors:  Mangatt P Biju; Aaron K Neumann; Steven J Bensinger; Randall S Johnson; Laurence A Turka; Volker H Haase
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

9.  An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects.

Authors:  A R Webster; F M Richards; F E MacRonald; A T Moore; E R Maher
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

10.  Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.

Authors:  E R Maher; A R Webster; F M Richards; J S Green; P A Crossey; S J Payne; A T Moore
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.